AxoGen, Inc.
AXGN · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 4.92 | -1.86 | 0.06 | -3.32 |
| FCF Yield | 0.21% | 1.42% | -1.61% | 1.07% |
| EV / EBITDA | 64.42 | 122.71 | 2,975.24 | 187.44 |
| Quality | ||||
| ROIC | 1.00% | 0.92% | -0.94% | 1.15% |
| Gross Margin | 76.55% | 74.16% | 71.94% | 76.06% |
| Cash Conversion Ratio | 4.55 | 13.35 | 3.44 | 19.41 |
| Growth | ||||
| Revenue 3-Year CAGR | 12.14% | 11.17% | 10.48% | 10.57% |
| Free Cash Flow Growth | -75.70% | 152.16% | -269.59% | 95.94% |
| Safety | ||||
| Net Debt / EBITDA | -0.33 | 9.63 | 168.95 | 9.88 |
| Interest Coverage | 0.19 | 0.85 | -0.74 | 1.12 |
| Efficiency | ||||
| Inventory Turnover | 0.35 | 0.40 | 0.38 | 0.36 |
| Cash Conversion Cycle | 141.34 | 130.59 | 153.39 | 235.44 |